selegiline has been researched along with 3,4-dihydroxyphenylglycol in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaarttinen, A; Kallio, J; Koulu, M; Pyykkö, K; Scheinin, M; Vuorinen, J; Zimmer, RH | 1 |
| Goldstein, DS; Hovevey-Sion, D; Kopin, IJ; Stull, RW | 1 |
| Eisenhofer, G; Goldstein, DS; Keiser, HR; Kopin, IJ; Murphy, DL; Stull, R; Sunderland, T | 1 |
| Ahlskog, JE; Low, PA; Nickander, KK; O'Brien, JF; Tyce, GM; Uitti, RJ | 1 |
| Illi, A; Koulu, M; Ojala-Karlsson, P; Scheinin, M | 1 |
| Caramona, M; Figueiredo, IV; Guimarães, S; Paiva, MQ | 1 |
| Adar, L; Goren, T; Sasson, N; Weiss, YM | 1 |
2 trial(s) available for selegiline and 3,4-dihydroxyphenylglycol
| Article | Year |
|---|---|
Inhibition of monoamine oxidase by moclobemide: effects on monoamine metabolism and secretion of anterior pituitary hormones and cortisol in healthy volunteers.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Benzamides; Blood Platelets; Catecholamines; Dose-Response Relationship, Drug; Double-Blind Method; Epinephrine; Homovanillic Acid; Humans; Hydrocortisone; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Norepinephrine; Pituitary Hormones, Anterior; Random Allocation; Selegiline; Vanilmandelic Acid | 1989 |
Clinical pharmacology tyramine challenge study to determine the selectivity of the monoamine oxidase type B (MAO-B) inhibitor rasagiline.
Topics: Adult; Aged; Algorithms; Contraindications; Diet; Dose-Response Relationship, Drug; Double-Blind Method; Drug Labeling; Female; Humans; Hypertension; Indans; Isoenzymes; Male; Methoxyhydroxyphenylglycol; Middle Aged; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Parkinson Disease; Selegiline; Tyramine; United States | 2010 |
5 other study(ies) available for selegiline and 3,4-dihydroxyphenylglycol
| Article | Year |
|---|---|
Effects of monoamine oxidase inhibitors on levels of catechols and homovanillic acid in striatum and plasma.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Catechols; Clorgyline; Corpus Striatum; Debrisoquin; Homovanillic Acid; Male; Methoxyhydroxyphenylglycol; Monoamine Oxidase Inhibitors; Nialamide; Norepinephrine; Rats; Rats, Inbred Strains; Selegiline | 1989 |
Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase.
Topics: Alzheimer Disease; Animals; Catecholamines; Chromatography, Liquid; Depression; Dihydroxyphenylalanine; Dogs; Glycols; Humans; Methoxyhydroxyphenylglycol; Monoamine Oxidase Inhibitors; Posture; Quality Control; Selegiline; Tranylcypromine | 1986 |
Levodopa and deprenyl treatment effects on peripheral indices of oxidant stress in Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Aged, 80 and over; Cysteinyldopa; Humans; Levodopa; Malondialdehyde; Methoxyhydroxyphenylglycol; Middle Aged; Oxidative Stress; Parkinson Disease; Selegiline | 1996 |
Norepinephrine metabolites in plasma as indicators of pharmacological inhibition of monoamine oxidase and catechol O-methyltransferase.
Topics: Antiparkinson Agents; Benzamides; Biomarkers; Catechol O-Methyltransferase Inhibitors; Catechols; Chromatography, High Pressure Liquid; Humans; Male; Methoxyhydroxyphenylglycol; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Nitriles; Norepinephrine; Pentanones; Selegiline | 1998 |
The role of MAO-A and MAO-B in the metabolic degradation of noradrenaline in human arteries.
Topics: Aged; Arteries; Clorgyline; Humans; Mandelic Acids; Methoxyhydroxyphenylglycol; Middle Aged; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Norepinephrine; Selegiline | 1998 |